Revolution Medicines (RVMD) EBT Margin (2019 - 2023)

Revolution Medicines' EBT Margin history runs 5 years deep, the most recent figure standing at 21724.26% for Q4 2023.

• In Q4 2023, EBT Margin fell 2135485.0% year-over-year to 21724.26%; the TTM figure through Sep 2024 stood at 76377.09% (down 7509565.0% YoY), while the FY2023 annual figure was 3798.71%, down 309457.0% from the prior year.
• EBT Margin was 21724.26% for Q4 2023 at Revolution Medicines, down from 2570.55% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 76.95% in Q1 2019 to a low of 21724.26% in Q4 2023.
• Historically, EBT Margin has averaged 1945.8% across 5 years, with a median of 386.72% in 2020.
• The sharpest annual moves came in 2022 and 2023: EBT Margin soared 261449 bps in 2022, then plunged 2135485 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 156.92% in 2019, then sank by 146 bps to 386.72% in 2020, then sank by 44 bps to 556.83% in 2021, then jumped by 34 bps to 369.41% in 2022, then tumbled by 5781 bps to 21724.26% in 2023.
• The last three EBT Margin figures came in at 21724.26% (Q4 2023), 2570.55% (Q2 2023), and 970.89% (Q1 2023), per Business Quant data.